               SEQUENCE LISTING

<110> Ablevia biotech GmbH

<120> Compound for the sequestration of undesirable antibodies in a patient

<130> R 76166

<150> EP 19164784.1
<151> 2019-03-23

<160> 23

<170> BiSSAP 1.3.6

<210> 1
<211> 20
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 1
Leu Lys Trp Asn Pro Asp Asp Tyr Gly Gly Val Lys Lys Ile His Ile 
1               5                   10                  15      
Pro Ser Glu Lys 
            20  

<210> 2
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 2
Trp Asn Pro Asp Asp Tyr Gly Gly Val Lys 
1               5                   10  

<210> 3
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 3
Val Lys Lys Ile His Ile Pro Ser Glu Lys 
1               5                   10  

<210> 4
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 4
Val Lys Lys Ile His Ile Pro Ser Glu Lys Gly 
1               5                   10      

<210> 5
<211> 15
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 5
Arg Pro Gln Lys Arg Pro Ser Cys Ile Gly Cys Lys Gly Thr His 
1               5                   10                  15  

<210> 6
<211> 15
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 6
Arg Pro Gln Lys Arg Pro Ser Cys Ile Gly Cys Lys Gly Ala His 
1               5                   10                  15  

<210> 7
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 7
Lys Arg Pro Ser Cys Ile Gly Cys Lys 
1               5                   

<210> 8
<211> 27
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 8
Met Ile Leu Asn Ser Ser Thr Glu Asp Gly Ile Lys Arg Ile Gln Asp 
1               5                   10                  15      
Asp Cys Pro Lys Ala Gly Arg His Asn Tyr Ile 
            20                  25          

<210> 9
<211> 15
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 9
Thr Ala Met Glu Tyr Arg Trp Pro Phe Gly Asn Tyr Leu Cys Lys 
1               5                   10                  15  

<210> 10
<211> 30
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 10
Ala Ile Ile His Arg Asn Val Phe Phe Ile Glu Asn Thr Asn Ile Thr 
1               5                   10                  15      
Val Cys Ala Phe His Tyr Glu Ser Gln Asn Ser Thr Leu Pro 
            20                  25                  30  

<210> 11
<211> 13
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 11
Asp Val Leu Ile Gln Leu Gly Ile Ile Arg Asp Cys Arg 
1               5                   10              

<210> 12
<211> 7
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 12
Ala Phe His Tyr Glu Ser Gln 
1               5           

<210> 13
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 13
Gly Arg Pro Gln Lys Arg Pro Ser Cys Ile Gly 
1               5                   10      

<210> 14
<211> 15
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 14
Cys Gly Arg Pro Gln Lys Arg Pro Ser Cys Ile Gly Cys Lys Gly 
1               5                   10                  15  

<210> 15
<211> 22
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 15
Leu Lys Trp Asn Pro Asp Asp Tyr Gly Gly Val Lys Lys Ile His Ile 
1               5                   10                  15      
Pro Ser Glu Lys Gly Cys 
            20          

<210> 16
<211> 13
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 16
Asp His Thr Leu Tyr Thr Pro Tyr His Thr His Pro Gly 
1               5                   10              

<210> 17
<211> 12
<212> PRT
<213> Artificial Sequence


<220> 
<223> peptide

<400> 17
Gly Gly Val Lys Lys Ile His Ile Pro Ser Glu Lys 
1               5                   10          

<210> 18
<211> 6
<212> PRT
<213> Artificial Sequence


<220> 
<223> Seq_18

<400> 18
Leu Gln Gln Gln Asn Thr 
1               5       

<210> 19
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Seq_19

<400> 19
Thr Thr Thr Gly Gln Asn Asn Asn Ser 
1               5                   

<210> 20
<211> 6
<212> PRT
<213> Artificial Sequence


<220> 
<223> Seq_20

<400> 20
Gly Thr Ala Asn Thr Gln 
1               5       

<210> 21
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Seq_21

<400> 21
Ile Pro Asn Pro Leu Leu Gly Leu Asp Cys 
1               5                   10  

<210> 22
<211> 23
<212> PRT
<213> Artificial Sequence


<220> 
<223> Seq_22

<400> 22
Ile Pro Asn Pro Leu Leu Gly Leu Asp Gly Gly Ser Gly Asp Tyr Lys 
1               5                   10                  15      
Asp Asp Asp Asp Lys Gly Lys 
            20              

<210> 23
<211> 24
<212> PRT
<213> Artificial Sequence


<220> 
<223> Seq_23

<400> 23
Val Lys Lys Ile His Ile Pro Ser Glu Lys Gly Gly Ser Gly Asp Tyr 
1               5                   10                  15      
Lys Asp Asp Asp Asp Lys Gly Lys 
            20                  

